Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
Titel:
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
Auteur:
Zhou, Caicun Wang, Ziping Sun, Yuping Cao, Lejie Ma, Zhiyong Wu, Rong Yu, Yan Yao, Wenxiu Chang, Jianhua Chen, Jianhua Zhuang, Wu Cui, Jiuwei Chen, Xueqin Lu, You Shen, Hong Wang, Jingru Li, Peiqi Qin, Mengmeng Lu, Dongmei Yang, Jason